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Molecular Analysis of Age and Sex-Related Gene
Expression in Meniscal Tears with and without a
Concomitant Anterior Cruciate Ligament Tear
Robert H. Brophy, MD, Muhammad Farooq Rai, PhD, Zhiqi Zhang, MD, Adelina Torgomyan, PhD, and Linda J. Sandell, PhD
Investigation performed at the Department of Orthopaedic Surgery, Washington University School of Medicine, St. Louis, Missouri

Background: The meniscus plays critical roles in the knee, contributing to load transmission, shock absorption, and joint
stability. Little is known about gene expression in meniscal tears, particularly in relation to injury pattern and patient age
and sex. The purpose of this study was to test the hypothesis that gene expression in meniscal tears varies depending on
patient age and sex and whether the anterior cruciate ligament (ACL) is also torn.
Methods: Meniscal tissue from twenty-eight patients with an isolated meniscal tear or a meniscal tear with a concomitant
ACL tear was collected at the time of clinically indicated partial meniscectomy. Messenger RNA (mRNA) expression was
examined by quantitative real-time polymerase chain reaction for molecular markers of osteoarthritis including proinflammatory cytokines (interleukin [IL]-1a, IL-1b, IL-6, and tumor necrosis factor-alpha [TNFa]), chemokines (IL-8, CCL3,
CCL3L1, CXCL1, CXCL3, CXCL6, and CCL20), aggrecanases (ADAMTS-4 [a disintegrin and metalloproteinase with thrombospondin type-4 motifs] and ADAMTS-5), matrix metalloproteinases (MMP-1, MMP-3, MMP-9, and MMP-13), transcription
factors (NFkB2 [nuclear factor kappa B2], NFkBIA [NF-kappa B inhibitor alpha], and IkBA [inhibitor of kappa B alpha]), and
matrix components (bone morphogenetic protein [BMP]-2, type-I collagen alpha 1 [Col1a1], Col2a1, and aggrecan).
Results: Expression of IL-1b (p = 0.02), ADAMTS-5 (p = 0.001), MMP-1 (p = 0.007), MMP-9 (p = 0.002), MMP-13 (p =
0.01), and NFkB2 (p = 0.01) was significantly higher in patients with a meniscal tear who were under the age of forty years
than it was in those over the age of forty years. Similarly, the expression of ADAMTS-4 (p = 0.002), ADAMTS-5 (p = 0.02),
MMP-1 (p = 0.02), and MMP-13 (p = 0.0002) was higher in patients with a meniscal tear and an ACL tear who were under
the age of forty years than it was in those over forty years. In patients with a meniscal tear and an ACL tear, the expression
of IL-1b (p = 0.01), TNFa (p = 0.02), MMP-13 (p = 0.004), CCL3 (p = 0.03), and CCL3L1 (p = 0.03) was significantly higher,
while that of aggrecan (p = 0.03) was lower, than that in patients with a meniscal tear alone. The only sex-based difference
in gene expression was higher levels of CCL3L1 in female patients (p < 0.05) of all ages with combined injuries.
Conclusions and Clinical Relevance: These findings suggest clinically relevant differences in the response of the knee to
meniscal tears on the basis of patient age and sex. Elevated expression levels of arthritis-related markers indicate an increased
catabolic response in patients under forty years old. Higher expression of catabolic markers in patients with meniscal and ACL
tears suggests this combined injury pattern is more likely to lead to the development of osteoarthritis. Catabolic activity in
meniscal tissue may predict patients who are at risk for progression of osteoarthritis following partial meniscectomy.
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more of the authors, or his or her institution, has had a financial
relationship, in the thirty-six months prior to submission of this work,
with an entity in the biomedical arena that could be perceived to
influence or have the potential to influence what is written in this work.
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always provided with the online version of the article.
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steoarthritis of the knee is a common condition and
a major cause of disability worldwide. Its complex
pathogenesis remains poorly understood but appears
multifactorial, with emerging evidence that osteoarthritis is
not merely an articular cartilage disease, but a disease of the whole
joint1,2, involving cartilage3, bone4, synovium5, and meniscus6,7. The
meniscus functions as a load-bearing8 and shock-absorbing9
part of the tibiofemoral joint. Surgical procedures on the
meniscus are the most commonly performed procedures in
orthopaedics10,11, and approximately 50% of people with meniscal tears have radiographic evidence of osteoarthritis ten to
twenty years after injury12. In the United States alone, 690,000
partial meniscectomies and almost one million additional knee
arthroscopies, most of which involve at least some debridement
of the meniscus, are performed each year13. An inverse relationship has been demonstrated between the function of the
knee and the amount of meniscal tissue resected14. Substantially
more cartilage degeneration and osteoarthritis have been found
in knees with a total meniscectomy than in those with a partial
meniscectomy15,16.
We previously reported catabolic and anabolic responses
to interleukin-1 (IL-1) and levels of gene expression in cartilage
from patients with osteoarthritis17. Little is known about the
metabolic activity of the meniscus at the time of resection and
its relationship to systemic levels of markers for inflammation
and for osteoarthritis. It is likely that the metabolic activity
of the meniscus is affected by the same processes in the knee
that affect the metabolic activity of the articular cartilage7.
Furthermore, the metabolic activity of the meniscus at the
time of meniscectomy may be predictive of future degenerative changes in the tibiofemoral joint. Thus, the activity of
the meniscal tissue resected at the time of meniscectomy may
provide important insight into the status of the overall joint
health and potentially differentiate patients at risk for future
progression of osteoarthritis. Gene expression in meniscal
tears may depend on a number of patient-related factors, including age and sex, as well as the injury pattern. The purpose
of this study was to test the hypothesis that gene expression
in meniscal tears varies depending on patient age and sex
and on whether the anterior cruciate ligament (ACL) is also
torn.
Materials and Methods
Tissue Acquisition and Processing

A

ll procedures were approved by the Washington University School of
Medicine human subjects institutional review board. Informed consent
was obtained from all subjects. Meniscal tissue was collected at the time of
clinically indicated partial meniscectomy from twenty-eight patients, including
twenty with a known meniscal tear and eight with a meniscal tear and a concomitant complete ACL tear, undergoing reconstruction by one of the authors
(R.H.B.) (Table I). None of the patients had advanced osteoarthritis or any
additional posterior cruciate or collateral ligament injury at the time of the
meniscal surgery.
The labeled specimens were transported to the laboratory from the
operating room in sterile phosphate-buffered saline solution (HyClone; Thermo
Fisher Scientific, Rockford, Illinois) in screw-cap containers. The tissues
were weighed and washed twice with phosphate-buffered saline solution.

M O L E C U L A R A N A LY S I S O F A G E A N D S E X -R E L AT E D
GENE EXPRESSION IN MENISCAL TEARS

The tissues were put in 50-mL tubes (Falcon; BD Biosciences, San Jose,
California), and 1 mL of TRIzol reagent (Invitrogen, Carlsbad, California) was
added per 50 to 100 mg of the tissue and kept at 280C until used for total RNA
extraction.

Total RNA Extraction
Each frozen tissue specimen was thawed and homogenized directly in TRIzol
reagent with use of a Polytron homogenizer (Brinkmann Instruments,
Westbury, New York). Aliquots of the homogenized suspension were transferred to microfuge tubes and incubated at room temperature for five minutes to permit the complete dissociation of nucleoprotein complexes.
Chloroform (200 mL) was added to each microfuge tube, which was shaken
for thirty seconds, incubated for two minutes at room temperature, and
centrifuged at 12,000 g for fifteen minutes at 4C. The upper aqueous phase
that contained RNA was moved to a clean microfuge tube, and 500 mL isopropanol was added to precipitate RNA. The tubes were incubated at room
temperature for ten minutes and centrifuged at 12,000 g for ten minutes at
4C. The RNA pellet was washed with 75% ethanol in water by centrifugation
at 7500 g for five minutes at 4C. The pellet was dried at 37C, resuspended in
RNase-free water (Qiagen, Valencia, California), and finally incubated at
60C for ten minutes. RNA was further purified by passing through RNeasy
Mini Spin Columns (Qiagen), and its yield and quality were assessed by
spectrophotometry with use of a NanoDrop spectrophotometer (Thermo
Fisher Scientific) and stored at 280C until reverse transcribed for complementary DNA (cDNA).

Reverse Transcriptase-Polymerase Chain Reaction
Prior to reverse transcriptase-polymerase chain reaction (RT-PCR), the isolated
RNA was treated with DNase I (Invitrogen) to remove traces of contaminating
DNA. In 0.2-mL tubes, 150 to 200 ng of total RNA, 2 mL of amplification grade
DNase I (1 U/mL), and 2 mL of DNase I reaction buffer (10X) were added in
total volume of 20 mL. The reaction mixture was incubated at room temperature for fifteen minutes followed by DNase I inactivation with 2 mL of 25 mM
EDTA at 65C for ten minutes.
The DNase-I-treated RNA was then reverse-transcribed into cDNA with
use of random hexamers and the SuperScript II First-Strand Synthesis System
(Invitrogen) as per the manufacturer’s instructions. Briefly, 2 mL of the random
primer (50 ng/mL) and 2 mL of dNTP mix (10 mM) were added to the tube
containing DNase-I-treated RNA, which was then incubated at 65C for five
minutes. The reaction mixture was chilled on ice, and the contents of the tubes
were collected by brief centrifugation. Reverse transcription was continued after
adding 14 mL of master mix (0.1 M DTT [dithiothreitol], 200 units/mL SuperScript II, and 5· first-strand buffer) and incubating at 42C for fifty minutes
followed by deactivation at 70C for fifteen minutes.

Quantitative Real-Time PCR
Transcript sequences for the housekeeping and target genes were obtained
from the National Center for Biotechnology Information (NCBI; www.
ncbi.nlm.nih.gov/). Primer sequences were designed by Primer Express 3
(Applied Biosystems, Foster City, California), and NCBI BLAST (Basic Local
Alignment Search Tool) searches were performed for all primer sequences to
confirm gene specificity. Custom-designed primers (see Appendix) were
obtained from Invitrogen. Gene expression analysis was performed on a 7500
Fast Real-Time PCR System (Applied Biosystems). The housekeeping gene
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) acted as an endogenous reference gene for normalization of fluorescence threshold (Ct) values
of target genes. In a 20-mL reaction volume, 10 mL of SYBR Green PCR
Master Mix (Applied Biosystems), 1.5 mL of cDNA, and 200 nM of primers
were added. Samples were amplified with an initial activation step at 95C for
ten minutes, followed by forty cycles of denaturation at 95C for fifteen
seconds and annealing at 60C for one minute. The Ct (fluorescence
threshold) values for GAPDH and the genes of interest were measured and
normalized to GAPDH for each sample (DCt). The comparative gene
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Fig. 1

Messenger RNA gene expression of cytokines (IL-1a, IL-1b, IL-6, and TNFa), chemokines (IL-8, CCL3, CCL3L1, CXCL1, CXCL-6, and CCL20), matrixdegrading genes (ADAMTS-4, ADAMTS-5, MMP-1, MMP-3, MMP-9, and MMP-13), matrix genes (BMP-2, Col1a1, Col2a1, and aggrecan), and transcription
factors (NFkB2, NFkBIA, and IkBA) in menisci obtained from young and old patients with a meniscal tear but without an ACL tear. Expression levels were
determined with use of quantitative real-time polymerase chain reaction with GAPDH (glyceraldehyde 3-phosphate dehydrogenase) as the reference. Values
are given as the mean and the standard error of the mean. *p < 0.05. #p < 0.01.

expression was calculated by X = 2–DDCt, where DDCt represents DCt(target) –
DCt(reference).

AR058978 (L.J.S.). The NIH also provided salary support (T32-AR060719) for
M.F.R.

Statistical Analysis

Results
Age-Related Gene Expression from Meniscal Tear Specimens
atients with a meniscal tear who were under forty years
old and those who were forty years or older were compared with respect to the expression of messenger RNA
(mRNA) for proinflammatory cytokines involved in osteoarthritis. The only significant difference was higher levels of
IL-1b in the young patients compared with that in the mature
patients (p = 0.02) (Fig. 1-A). There were no significant
differences in the expression of chemokines between these
two groups (Fig. 1-B). Gene expression of matrix-degrading
enzymes, such as aggrecanases and metalloproteinases, demonstrated significantly higher levels of ADAMTS-5 (a disintegrin and metalloproteinase with thrombospondin type-5
motifs) (p = 0.001) as well as matrix metalloproteinase (MMP)1 (p = 0.007), MMP-9 (p = 0.002), and MMP-13 (p = 0.01) in
patients under forty years of age (Fig. 1-C). There were no
significant differences in the expression of mRNA for matrix
molecules that constitute menisci (Fig. 1-D). The expression
of transcription factors involved in the osteoarthritis pathway

Gene expression was compared by patient age and sex and by injury pattern
(meniscal tear compared with combined meniscal and ACL tears). Patients
under forty years old are more likely to sustain traumatic meniscal tears,
7
while the prevalence of degenerative tears increases with patient age . Since
torn menisci in patients over forty years of age have been shown to have lower
18
cellularity compared with torn menisci in patients under forty years of age ,
we compared gene expression in patients under forty years (young) with
gene expression in patients forty years and older (mature). Significance
between the groups was determined with use of a two-tailed unpaired t
test with unequal variance, and significance levels were calculated with the
Mann-Whitney U test. Significance based on sex was determined by analysis
of variance followed by Bonferroni post hoc analyses. All statistics were performed with use of GraphPad (GraphPad Software, San Diego, California). A
p value of <0.05 was considered significant. Values presented in the text, figures,
and tables are given as the mean and the standard error of the mean.

Source of Funding
Funding for this study was provided by a grant from the Orthopaedic
Research and Education Foundation (R.H.B.), National Institute of Arthritis
and Musculoskeletal and Skin Diseases grant RO1-AR036994 (L.J.S.),
and National Institutes of Health (NIH) Grand Opportunity Grant RC2-

P
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TABLE I Demographic Data
Meniscal
Tear

Meniscal Tear
and ACL Tear*

All patients
Male
Female
Total
Mean age (range) (yr)

11
9
20
41.5 (14-60)

5
3
8
26.8 (16-59)

Patients <40 yr old
Male
Female
Total
Mean age (range) (yr)

3
5
8
25.5 (14-36)

4
2
6
19 (16-27)

Patients ‡40 yr old
Male
Female
Total
Mean age (range) (yr)

8
4
12
52.2 (41-60)

1
1
2
50.5 (42-59)

*ACL = anterior cruciate ligament.

M O L E C U L A R A N A LY S I S O F A G E A N D S E X -R E L AT E D
GENE EXPRESSION IN MENISCAL TEARS

demonstrated significantly higher levels of NFkB2 (nuclear
factor kappa B2) (p = 0.01) in patients under forty years (Fig.
1-E).
Age-Related Gene Expression from Meniscal Tear and ACL
Tear Specimens
There was no significant age-related difference in the expression of proinflammatory cytokines (Fig. 2-A) or chemokines (Fig. 2-B) between young and mature patients with a
combined injury pattern (a meniscal tear and an ACL tear).
However, the expression of both ADAMTS-4 (p = 0.002) and
ADAMTS-5 (p = 0.02) was significantly higher in patients
with a combined injury pattern who were under forty years
old than it was in those over forty years old. The expression
levels of MMP-1 (p = 0.02) and MMP-13 (p = 0.0002) were
higher in patients with a combined injury pattern who were
under forty years old than in those who were over forty (Fig.
2-C). There was a higher expression of matrix genes in the
patients over forty years old. Although all of the genes for
matrix components were expressed at lower levels in the patients under forty years old, the age-related difference was not
significant for these genes (Fig. 2-D). For the transcription

Fig. 2

Messenger RNA gene expression of cytokines (IL-1a, IL-1b, IL-6, and TNFa), chemokines (IL-8, CCL3, CCL3L1, CXCL1, CXCL-6, and CCL20), matrixdegrading genes (ADAMTS-4, ADAMTS-5, MMP-1, MMP-3, MMP-9, and MMP-13), matrix genes (BMP-2, Col1a1, Col2a1, and aggrecan), and transcription
factors (NFkB2, NFkBIA, and IkBA) in menisci obtained from young and old patients with a meniscal tear and an ACL tear. Expression levels were determined
with use of quantitative real-time polymerase chain reaction with GAPDH (glyceraldehyde 3-phosphate dehydrogenase) as the reference. Values are given as
the mean and the standard error of the mean. *p < 0.05. #p < 0.01.
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Fig. 3

Messenger RNA gene expression of cytokines (IL-1a, IL-1b, IL-6, and TNFa), chemokines (IL-8, CCL3, CCL3L1, CXCL1, CXCL-6, and CCL20), matrixdegrading genes (ADAMTS-4, ADAMTS-5, MMP-1, MMP-3, MMP-9, and MMP-13), matrix genes (BMP-2, Col1a1, Col2a1, and aggrecan), and transcription
factors (NFkB2, NFkBIA, and IkBA) in menisci obtained from patients with combined meniscal and ACL tears (MT 1 ACL) and those without an ACL tear (MT).
Expression levels were determined with use of quantitative real-time polymerase chain reaction with GAPDH (glyceraldehyde 3-phosphate dehydrogenase)
as the reference. Values are given as the mean and the standard error of the mean. *p < 0.05. #p < 0.01.

factors, the gene expression was significantly higher for IkBA
(inhibitor of kappa B alpha) (p = 0.01) in patients under forty
years old, although NFkBIA (NF-kappa B inhibitor alpha)
and NFkB2 were increased in these patients by 3.2-fold and
1.2-fold (Fig. 2-E).
Comparison of Gene Expression Between the Group with
a Meniscal Tear and the Group with a Meniscal Tear
and an ACL Tear
When we compared the tissues from patients with a meniscal
tear and the tissues from patients with a meniscal tear and an
ACL tear with respect to gene expression of proinflammatory
cytokines, the expression levels of IL-1a and IL-6 were equal
in both groups. There was a significant increase in the expression of IL-1b (p = 0.01) and tumor necrosis factor alpha
(TNFa) (p = 0.02) in the tissue from the patients with a
meniscal tear and an ACL tear compared with that from patients with a meniscal tear alone (Fig. 3-A). For the chemokines, there was a significantly higher expression of CCL3 (p =
0.03) and CCL3L1 (p = 0.03) in the tissue from patients with a
combined meniscal and ACL tear. The expression of IL-8 was
equal in both groups (Fig. 3-B). The expression of MMP-13
(p = 0.004) was higher in the meniscal and ACL tear group,

but none of the other genes for matrix-degrading enzymes
were significantly different between the two groups. Also, the
expression of MMP-3 was slightly higher (1.3-fold) in the
meniscal and ACL tear group. In contrast, the expression was
less, although it was not significantly different, for ADAMTS-4
(2.4-fold), MMP-1 (1.6-fold), and MMP-9 (1.3-fold) in this
group. ADAMTS-5 was equally expressed in both groups (Fig.
3-C). From the genes for matrix components (Fig. 3-D) as well
as transcription factors (Fig. 3-E), only aggrecan was significantly (p = 0.03) lower in patients with a combined meniscal
and ACL tear. Except for the bone morphogenetic protein
(BMP)-2, the expression of all other matrix genes and transcription factors was less in the combined meniscal and ACL
tear group. However, these differences in gene expression were
not significant.
Sex-Based Differences in Gene Expression
The analysis of variance results showed that expression of
CCL3L1 was significantly greater in female patients with
combined meniscal and ACL tears than in male patients with
combined meniscal and ACL tears (p < 0.05) as well as in male
(p < 0.01) and female patients (p < 0.001) from the isolated
meniscal tear group. There was no significant difference among
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TABLE II Normalized Expression Levels in Menisci Obtained at the Time of Clinically Indicated Partial Meniscectomy in Patients with
and without a Concomitant ACL Tear
Meniscal Tear*

Meniscal Tear and ACL Tear*

Genes

Male

Female

Male

Female

Proinflammatory cytokines
IL-1a
IL-1b
IL-6
TNFa

0.89 ± 0.61
0.56 ± 0.23
0.72 ± 0.31
0.49 ± 0.13

1.00 ± 0.41
1.00 ± 0.37
1.00 ± 0.36
1.00 ± 0.35

0.67 ± 0.17
1.01 ± 0.21
0.72 ± 0.50
1.87 ± 0.67

1.09 ± 0.33
2.14 ± 0.18
1.05 ± 0.39
2.37 ± 0.56

Chemokines
IL-8
CCL3
CCL3L1
CXCL1
CXCL3
CXCL6
CCL20

2.38 ± 1.00
0.22 ± 0.06
1.66 ± 0.80†
1.05 ± 0.37
0.32 ± 0.06
1.00 ± 0.55
0.90 ± 0.41

1.00 ± 0.45
1.00 ± 0.45
1.00 ± 0.39‡
1.00 ± 0.26
1.00 ± 0.35
1.00 ± 0.31
1.00 ± 0.56

2.83 ± 1.46
1.53 ± 1.15
1.38 ± 0.42§
3.18 ± 1.66
0.85 ± 0.39
3.69 ± 2.14
1.52 ± 0.47

0.54 ± 0.15
1.64 ± 0.42
6.14 ± 1.49†‡§
3.31 ± 1.19
1.40 ± 0.37
1.05 ± 0.20
4.63 ± 1.76

Matrix-degrading enzymes
ADAMTS-4
ADAMTS-5
MMP-1
MMP-3
MMP-9
MMP-13

0.14 ± 0.09
0.38 ± 0.21
0.46 ± 0.23
0.96 ± 0.29
0.58 ± 0.35
1.24 ± 0.89

1.00 ± 0.56
1.00 ± 0.29
1.00 ± 0.40
1.00 ± 0.29
1.00 ± 0.52
1.00 ± 0.30

0.22 ± 0.07
0.71 ± 0.30
0.48 ± 0.19
0.42 ± 0.11
0.39 ± 0.20
4.02 ± 1.05

0.22 ± 0.05
0.47 ± 0.09
0.39 ± 0.09
2.59 ± 0.36
0.99 ± 0.29
2.79 ± 0.42

Matrix genes
BMP-2
Col1a1
Col2a1
Aggrecan

0.59 ± 0.39
0.94 ± 0.90
1.25 ± 0.57
0.51 ± 0.22

1.00 ± 0.36
1.00 ± 0.63
1.00 ± 0.44
1.00 ± 0.55

1.14 ± 0.92
0.37 ± 0.21
0.06 ± 0.02
0.05 ± 0.01

2.53 ± 0.63
1.41 ± 0.53
0.05 ± 0.003
0.05 ± 0.01

Transcription factors
NFkB2
NFkBIA
IkBA

0.72 ± 0.34
0.15 ± 0.05
0.70 ± 0.41

1.00 ± 0.41
1.00 ± 0.64
1.00 ± 0.58

0.75 ± 0.45
0.10 ± 0.05
0.18 ± 0.05

0.54 ± 0.12
0.55 ± 0.12
0.30 ± 0.05

*Data expressed as the mean and the standard error of mean. ACL = anterior cruciate ligament. †The difference was significant (p < 0.01). ‡The
difference was significant (p < 0.001). §The difference was significant (p < 0.05).

the expression of other genes based on sex and pattern of injury
(Table II).
Discussion
ene expression in meniscal tears varies by patient age, sex,
and injury pattern. Younger patients (those under forty
years of age) have greater expression of degradative enzymes
and NFkB2, a transcription factor involved in the inflammatory and catabolic events in osteoarthritis. The presence of an
associated ACL tear increases the expression of the proinflammatory cytokines IL-1b and TNFa, chemokines CCL3 and
CCL3L1, and the matrix-degrading enzyme MMP-13. Combined meniscal and ACL injury also results in less expression
for the matrix component aggrecan in meniscal tissue compared with an isolated meniscal tear. Thus, the meniscus ap-

G

pears to undergo more substantial changes in gene expression
as a result of combined injury.
There is a significant effect of patient age and sex, as well
as injury pattern, on the expression of osteoarthritis-related
genes in the human meniscus. The expression pattern of multiple proinflammatory cytokines, chemokines, matrix-degrading
enzymes, matrix genes, and transcription factors is an important consideration in the molecular characterization of osteoarthritis2. Among patients with an isolated meniscal tear, those
younger than forty years had elevated levels of several of the
osteoarthritis-related genes compared with patients older than
forty years. For example, IL-1b, ADAMTS-5, MMP-1, MMP-9,
MMP-13, and NFkB2 were expressed significantly higher in
meniscal tears from patients under forty years. In parallel, although not significant, the expression of matrix genes BMP-2,
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type-I collagen alpha 1 (Col1a1), Col2a1, and aggrecan was
lower in patients under forty years than those over forty. Interestingly, none of the arthritis-related genes was upregulated
in patients over forty except for IL-8 and CCL20, although their
expression was also not significant. These findings indicate that
the meniscus in young individuals has more intrinsic response
and is more prone to inflammatory changes after an isolated
meniscal tear. This observation is consistent with the greater
prevalence of traumatic tears in younger patients7 that are associated with an increased risk of osteoarthritis development19,
and it provides a molecular rationale for the increased risk of
osteoarthritis.
The age-related gene expression pattern of meniscal tears
associated with ACL rupture revealed that the elevated expression of genes in patients under forty years of age was limited to
ADAMTS-4, ADAMTS-5, MMP-1, MMP-13, and IkBA. With
the exception of ADAMTS-4 and IkBA, all other genes were also
significantly upregulated in patients under forty years old with
an isolated meniscal tear. Thus, it appears that aggrecanases and
matrix metalloproteinases are consistently expressed at higher
levels in patients under forty years old with meniscal tears, with
or without a concomitant ACL tear.
Articular cartilage degeneration in osteoarthritis is thought
to result from a metabolic imbalance in the joint characterized
by the upregulation of aggrecanases (especially ADAMTS-4 and
ADAMTS-5), resulting in the degradation of aggrecan20. Similarly, the excessive cleavage of type-II collagen in osteoarthritis
is also assumed to be caused by the upregulation of the synthesis and activities of collagenases21, in particular MMP-1322.
Both ADAMTS-4 and ADAMTS-5 are major aggrecan-degrading
enzymes and have been previously implicated in the degradation of articular cartilage23,24. The elevated expression of these
genes in meniscal tissues suggests that they may play a pivotal
role in subsequent joint degeneration.
Our results suggest that early changes in the joint following
a meniscal tear include increased expression of matrix-degrading
genes. This overexpression likely results in the degradation of
both aggrecan and collagen. There is also a decreased expression of matrix genes in menisci with isolated tears. However,
as mentioned previously, not many proinflammatory genes
differed between young and mature patients with combined
meniscal and ACL injury. Only MMP-13 was expressed at
significantly higher levels in patients with a combined meniscal and ACL tear compared with those with an isolated
meniscal tear. Conversely, the expression of aggrecan and
Col2a1 was lower in the combined meniscal and ACL tear
group, which could explain increased degradation of extracellular matrix following ACL rupture with less potential for
repair. Furthermore, the expression of IL-1b and TNFa was
also significantly higher in patients with a meniscal and ACL
tear. These master proinflammatory cytokines play key roles
in the initiation and progression of the osteoarthritis disease
process25-27. Their increased expression signifies the severity of
inflammation associated with a combined ACL and meniscal
injury and likely explains elevated degradation of extracellular
matrix.
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Only two chemokines, CCL3 and CCL3L1, were significantly upregulated in patients with meniscal and ACL tears.
Both of these chemokines are proinflammatory in nature and
are known to enhance the inflammatory responses28,29, and they
may be involved in articular cartilage destruction. This also
indicates that a combined meniscal and ACL tear has a greater
acute inflammatory response compared with an isolated meniscal tear.
Further information can be derived through the expression pattern of transcription factors involved in the inflammatory cascade of arthritis. Significantly higher levels of
NFkB2 in patients with a meniscal tear who were under forty
years of age correlated well with the higher expression of
downstream inflammatory genes in these patients. However,
substantially higher expression of IkBA in patients with a
meniscal and ACL tear who were under forty years might indicate an early NFkB-dependent upregulation of IkBA. This
overexpression of IkBA further explains the lower levels of
NFkB2 in these patients through a negative feedback loop
mechanism.
The findings from the present study are clinically relevant
in several ways. First, these differences in gene expression may
relate to the worse long-term clinical outcomes after meniscal
repair seen in older patients30. Although short-term clinical
success rates are good in patients older than forty years31, these
patients have reportedly lower rates of meniscal healing and
higher long-term failure rates after repair. As a lack of viable
cells in the meniscus is associated with degeneration and repeat
tearing, one possible physiologic reason for higher late failure
rates in older patients may be the decreased intrinsic and
perimeniscal cellularity found in the torn menisci of this patient group18. Differences in gene expression and intrinsic
inflammation may contribute to this difference in healing
potential as well. The relationship between a catabolic response
of the meniscus at the time of meniscal resection and patient
age could be used in the future to help guide the clinical decision of whether to repair or resect the torn meniscus.
Perhaps more importantly, the level of catabolic activity
may allow for the classification of patients who in the future
could be predicted to develop progression of osteoarthritis
following partial meniscectomy. This identification of patients
at risk for progression of osteoarthritis following partial
meniscectomy could facilitate studies of possible interventions
such as activity modification, weight loss, pharmaceuticals,
injections, or meniscal replacement or transplantation to slow
or arrest this progression to osteoarthritis.
It has been widely reported that osteoarthritis is more
common in women than in men32,33. It has been reported that
meniscal tears, diagnosed by magnetic resonance imaging, are
very common in older women with knee osteoarthritis, particularly in the medial compartment of the knee. However, the
reasons for this association have been unclear34. On the basis of
our findings, a reasonable expectation would have been higher
expression of osteoarthritis-related genes after meniscal tears in
female patients. However, surprisingly, there was no strong
evidence to support this hypothesis. The only osteoarthritis-
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related gene that was significantly greater in females was
CCL3L1. The clinical implications of this finding are not clear
at this time and warrant further investigation.
This study has a number of limitations. First, all of these
values are from injured menisci. There are no data on values in
healthy, uninjured menisci for comparison. Second, a variety
of other factors such as general health conditions, body mass
index, smoking status, joint health, and patient variance could
influence gene expression in meniscal tissue. The relationship
of meniscal gene expression to articular cartilage degeneration
in the joint and potential progression of cartilage degeneration
is unknown. Finally, we did not account for the compartment
of the torn meniscus (medial vs. lateral), the location of the tear
within the meniscus, or the synovial fluid, all of which could
potentially relate to gene expression.
In summary, gene expression in meniscal tears varies by
patient age, sex, and injury pattern. Our findings suggest that
elevated expression levels of osteoarthritis-specific markers
indicate an increased catabolic (inflammatory) response in
patients under forty years of age with meniscal tears. Furthermore, higher expression of inflammatory markers in
patients with a combined meniscal and ACL injury suggests
the combined injury pattern is more likely to lead to the
development of osteoarthritis. Catabolic activity may be predictive of patients at risk for progression of osteoarthritis
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following partial meniscectomy and ACL reconstruction.
Further investigation of gene expression in torn menisci from
these patients may reveal novel disease markers for early
osteoarthritis and potentially identify new therapeutic targets
for therapy to delay or prevent osteoarthritis after meniscal
injury.
Appendix
A table showing the primers for quantitative real-time
polymerase chain reaction is available with the online
version of this article as a data supplement at jbjs.org. n
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